Showing results (651-660 of 785) with videos related to

Sort By:
Pageof 79
Alimentary Pharmacology & Therapeutics|April 30, 2020
Review article: prevention, diagnosis and management of COVID-19 in the IBD patientAysha H Al-Ani, Ralley E Prentice, Clarissa A Rentsch, et al.
Crohn'S & Colitis 360|March 30, 2026
Impact of mirikizumab on patient-reported outcomes and quality of life in patients with Crohn's disease: results from the phase 2 SERENITY studyVipul Jairath, Theresa Hunter Gibble, Laurent Peyrin-Biroulet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 10, 2023
Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World ExperienceScott Friedberg, David Choi, Thomas Hunold, et al.
Diseases of the Colon and Rectum|December 13, 2018
Abnormal Pouchogram Predicts Pouch Failure Even in Asymptomatic PatientsPhilip H Sossenheimer, Laura R Glick, Abraham H Dachman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 13, 2015
Low-Magnitude Mechanical Stimulation to Improve Bone Density in Persons of Advanced Age: A Randomized, Placebo-Controlled TrialDouglas P Kiel, Marian T Hannan, Bruce A Barton, et al.
Gastroenterology|March 31, 2018
Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's DiseaseSilvio Danese, Stefanos Bonovas, Anthony Lopez, et al.
Inflammatory Bowel Diseases|March 8, 2016
Patients with Ulcerative Colitis Are More Concerned About Complications of Their Disease than Side Effects of MedicationsKimberly D Thompson, Susan J Connor, Danielle M Walls, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2020
Long-term safety of vedolizumab for inflammatory bowel diseaseEdward V Loftus, Brian G Feagan, Remo Panaccione, et al.
Pageof 79